ArticlePeerJ2025
Trends in dyslipidemia prevalence among Uyghur adults of different genders in China: a retrospective cohort study.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Machine learning and SHAP values for predicting coronary artery disease risk in Xinjiang, China.European journal of medical research · 2026Article
- A serial 4-year cross-sectional study of dyslipidemia on Pamirs Plateau, the roof of the world.BMC medicine · 2025Article
- Cost-Effectiveness Analysis of Pitavastatin in Dyslipidemia: Vietnam Case.Healthcare (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To analyze the prevalence and epidemiological characteristics of dyslipidemia among adults of different genders in Xinjiang, China, providing a basis for promoting ideal lipid management among the Uyghur population. Methods: In this retrospective study, we included 7,646 Uyghur adults from the 2021 physical examination data in Hotan, Xinjiang, and followed up with all participants in 2023 for analysis. Participants completed lifestyle and medical history questionnaires and underwent lipid profiling. Dyslipidemia was defined according to the 2023 Chinese guidelines for lipid management. Group differences were analyzed using Results: In 2023, the average levels of waist circumference, fasting glucose, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and non-HDL-C among Uyghur men and women, as well as the prevalence of diabetes, increased compared to 2021, with significant statistical differences within the same gender groups ( Conclusion: The primary forms of dyslipidemia among Uyghur adults include low HDL-C levels. The prevalence of high LDL-C, hypertriglyceridemia, and low HDL-C is showing a declining trend, particularly among men. In contrast, the prevalence of hypercholesterolemia and high non-HDL-C is increasing more significantly among women. In men, risk factors for dyslipidemia include higher educational attainment, being overweight, obesity, and central obesity. In women, the prevalence of dyslipidemia is mainly associated with obesity and central obesity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.